Nile Blue

Nile Blue

SCHEMBL29356294

CCN(CC)c1ccc2nc3c4ccccc4c(=N)cc-3oc2c1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.77
KMT2A Q03164 10/20 0.77
NPC1 O15118 5/20 0.77
RAB9A P51151 4/20 0.77
POLB P06746 3/20 0.77
SCP2 P22307 1/20 0.48
ALDH1A1 P00352 8/20 0.40
KDM4E B2RXH2 6/20 0.40
L3MBTL1 Q9Y468 5/20 0.40
GLA P06280 3/20 0.40
TERT O14746 1/20 0.39
MAPT P10636 9/20 0.39
CASP1 P29466 4/20 0.39
CASP7 P55210 4/20 0.39
HTT P42858 4/20 0.39
HSD17B10 Q99714 3/20 0.39
TP53 P04637 2/20 0.39
BRCA1 P38398 2/20 0.39
ALOX15 P16050 1/20 0.39
MPI P34949 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nile Blue SCHEMBL12393690 1.00 MEN1 (0.77) MEN1KMT2ANPC1RAB9APOLB
Nile Blue SCHEMBL4051129 0.93 MEN1 (0.71) MEN1KMT2ANPC1RAB9APOLB
Nile Blue SCHEMBL4051132 0.93 MEN1 (0.71) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL18070239 0.87 MEN1 (0.62) MEN1KMT2ANPC1RAB9APOLB
Nile Red SCHEMBL29373685 0.87 MEN1 (1.00) MEN1KMT2ANPC1RAB9APOLB
Nile Red SCHEMBL49047 0.87 MEN1 (1.00) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL22372426 0.87 MEN1 (0.75) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL23733292 0.86 MEN1 (0.58) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL16696324 0.86 MEN1 (0.61) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL16696323 0.85 KMT2A (0.63) MEN1KMT2ANPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12616656-B2 Adventitial painting modality of local drug delivery to abate intimal hyperplasia UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2026-05-05 US claimed
CN-121577876-A Raman detection method of macromolecular antigen 宁波大学 2026-02-27 CN claimed
EP-4661729-A1 METHOD FOR OPERATING A DISHWASHER WITH A MEASUREMENT UNIT FOR MEASURING A PH-VALUE OF THE WASHING LIQUOR V-Zug AG (CH) 2025-12-17 EP claimed
US-20250339812-A1 ELECTROCHEMICAL DIRECT AIR CAPTURE OF CARBON DIOXIDE USING REVERSIBLE REDOX-ACTIVE MATERIAL MASSACHUSETTS INST TECHNOLOGY (US) 2025-11-06 US claimed
EP-4313156-B1 DISULFIDE-BASED PRODRUG COMPOUNDS UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2025-08-06 EP claimed
CN-115508329-B Method for detecting novel coronavirus N protein based on surface enhanced Raman spectrum 厦门大学 2025-06-03 CN claimed
CN-120060509-A Active and dead bacteria synchronous detection sensor based on Cas12-Cas13 combination, detection method and application 安徽医科大学 2025-05-30 CN claimed
CN-120064407-A PH sensing method for realizing electrochemical calibration-free based on dynamic current technology 常州江苏大学工程技术研究院 2025-05-30 CN claimed
EP-3419542-B1 METHOD AND APPARATUS FOR TIGHTENING SKIN MASSACHUSETTS GEN HOSPITAL (US) 2025-05-14 EP claimed
US-20250143865-A1 METHODS AND SYSTEMS FOR PREVENTING OR REDUCING STENOSIS IN A SUBJECT RECEIVING A GRAFT MASSACHUSETTS GEN HOSPITAL (US) 2025-05-08 US claimed
WO-2022144421-A1 A SURFACE ENHANCED RAMAN SCATTERING (SERS) COMPOSITION COMPRISING METAL NANOPARTICLES (NPS) AGGLOMERATES UNIVERSITAT POMPEU FABRA (ES) 2022-07-07 WO claimed
EP-4024032-A1 A SURFACE ENHANCED RAMAN SCATTERING (SERS) COMPOSITION COMPRISING METAL NANOPARTICLES (NPS) AGGLOMERATES Universitat Pompeu Fabra (ES) 2022-07-06 EP claimed
US-11340204-B2 System for managing and trading fresh foods according to flavor and method thereof TAIWAN CARBON NANO TECHNOLOGY CORPORATION (TW) 2022-05-24 US claimed
US-11337792-B2 Methods for tissue passivation THE GENERAL HOSPITAL CORPORATION (US) 2022-05-24 US claimed
US-11326989-B2 Devices and methods for tissue and cell staining ESSENLIX CORPORATION (US) 2022-05-10 US claimed
CN-113358626-B SERS technology-based rapid detection method for trace acetylcholinesterase 东南大学 2022-04-26 CN claimed
CN-109152605-B Apparatus and method for tightening skin and other tissue 通用医疗公司 2022-04-19 CN claimed
CN-114354917-A Target vertical current array immunodetection device and detection method 中国农业科学院北京畜牧兽医研究所 2022-04-15 CN claimed
US-20220065794-A1 SYSTEM AND METHOD FOR LOGISTICS MANAGEMENT BASED ON ODOR MOLECULES TAIWAN CARBON NANO TECHNOLOGY CORPORATION (TW) 2022-03-03 US claimed
CN-114118197-A System and method for carrying out logistics management based on odor molecules 台湾奈米碳素股份有限公司 2022-03-01 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12616656-B2 Adventitial painting modality of local drug delivery to abate intimal hyperplasia ADRA1B, ADRB1, ADRB3 MEN1 4609/4885KMT2A 3337/4885NPC1 2389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.